Salta al contenuto principale
Passa alla visualizzazione normale.

Ricerca avanzata per:

Risultati della ricerca

  • 1. Matematica CTF 5.3.14 Risultati e calendario colloqui (100%)

    6-mar-2014 16.57.54

    Microsoft® Word 2010 Trial Microsoft® Word 2010 Trial

  • 2. PROGRAMMA MATEMATICA e FISICA CTF 13/14 (89%)

    24-ott-2013 12.23.24

    93/94 programma, ctf, corso Antonio B Microsoft® Word 2010 Trial Microsoft® Word 2010 Trial

  • 3. IRI organigramma societario (83%)

    26-mar-2015 15.49.07

    I9 34 , u J _ o - us trial 3È cs x È z 6 ,.iN G r aOl l ì - z a! - . r . ' l . l : . : .z a t ron I ÉOJ. r , r r c h f ' ' - ' 5 ' c . : : c r l o r 6 - - L l r rcd rg . , , ì par t Y 6 , : th the I t ; f A OJ co ' .=ò- =. . t i re ;- ai . . : l e : St O = : t 'api- 6 : r]i :r-t-t's ó N Ot € g x , : Ìr that Ot- c . . : O X : - .L la l ih G r r è < . U O G àE : i r and O È c o ú .U . . : \ i ìP - c , : r c o s t .ro o = a) ' . , , , r 1d , c ' N . , r r ti n f

  • 4. Legenda dataset (78%)

    9-lug-2015 10.50.35

    LEGENDA DATASET Tab. 1 Description of trials included in the meta-analysis Meta- Author Publisher Treatment* # of # of trials # of trial analysis Ctr exp trials eliminated included 1 Myers RP et al, The Cochrane Untreated or IFN1 54 31 23 2002 Collaboration placebo 2 Brok J et al, The Cochrane IFN1 IFN2 72 54 18 2006 Collaboration 3 Hauser G et al, The Cochrane IFN1 or IFN2 IFN3 27 12 15 2014 Collaboration 4 Chou R et al, Ann Int Med IFN3 IFN4 5 0 5 2013 Total 158 97 61

  • 5. Dataset Meta-Analysis HCV (70%)

    9-lug-2015 10.50.28

    Foglio1 Meta-analysis Group Author Journal Year of publication Trial* Arm Type Patient Type Treatment SVR ITT 1 Camps J Hepatol 1993 1 exp naive interferon (IFN1) 13 36 1 Capra J Hepatol 1993 2 exp naive interferon (IFN1) 12 20 1 Causse Gastroenterology 1991 3 exp naive interferon (IFN1) 4 30 1 Causse Gastroenterology 1991 3 exp naive interferon (IFN1) 1 30 1 Cimino Ital J Gastroenter 1991 4 exp naive interferon (IFN1) 10 33 1 Davis N Eng J Med 1989 5 exp naive interferon (IFN1) 22 58 1

  • 6. 2012_XIV_rapporto_IEM (68%)

    23-set-2013 16.25.27

  • 7. Progetto PRIN ATTANASIO (63%)

    17-set-2019 20.22.36